Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

Ohio State University1,320 enrolled

Overview

The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated today.

Study Type

OBSERVATIONAL

Enrollment

1,320

Conditions

Sepsis, Severe Sepsis and Septic Shock

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Adult (≥18 to 90 years) * Patients presenting to the Emergency Department * CBC (Complete Blood Count) with differential testing performed and CPD data retrieved Exclusion Criteria: * Previously enrolled in this study

Locations (1)

Wexner Medical Center at The Ohio State University

Columbus, Ohio, United States

Outcomes

Primary Outcomes

We are measuring CBC (complete blood count) and MNV (Mean Neutrophil Volume)

Evaluate the clinical utility of CPD MNV as an aid in the diagnosis and risk assessment of Emergency Department patients for progression to sepsis, severe sepsis and septic shock.

Time frame: approximately 10 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.